Skip to main content
TipRanks
Go Ultimate75% OFF

BioNTech SE (0A3M) Stock Statistics & Valuation Metrics

6 Followers

Total Valuation

BioNTech SE has a market cap or net worth of $21.14B. The enterprise value is $9.59B.

Market Cap
$21.14B
Enterprise Value
$9.59B

Share Statistics

BioNTech SE has 251,204,360 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
251,204,360
Owned by Insiders
15.80%
Owned by Institutions
16.00%

Financial Efficiency

BioNTech SE’s return on equity (ROE) is -0.06 and return on invested capital (ROIC) is -3.14%.

Return on Equity (ROE)
-0.06
Return on Assets (ROA)
-0.05
Return on Invested Capital (ROIC)
-3.14%
Return on Capital Employed (ROCE)
-0.03
Revenue Per Employee
353.10K
Profits Per Employee
-139.78K
Employee Count
7,807
Asset Turnover
0.13
Inventory Turnover
5.57

Valuation Ratios

The current PE Ratio of BioNTech SE is -13.27. BioNTech SE’s PEG ratio is 0.14.

PE Ratio
-13.27
PS Ratio
8.03
PB Ratio
1.10
Price to FCF
-41.29
Price to Operating Cash Flow
-79.27
PEG Ratio
0.14

Income Statement

In the last 12 months, BioNTech SE had revenue of 2.76B and earned -1.09B in profits. Earnings per share was -4.51.

Revenue
2.76B
Gross Profit
2.14B
Operating Income
-623.87M
Pretax Income
-1.01B
Net Income
-1.09B
EBITDA
-628.00M
Earnings Per Share (EPS)
-4.51

Cash Flow

In the last 12 months, operating cash flow was -247.56M and capital expenditures -208.64M, giving a free cash flow of -456.19M billion.

Operating Cash Flow
-247.56M
Free Cash Flow
-456.19M
Free Cash Flow per Share
-1.88

Dividends & Yields

BioNTech SE pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
-2.42%
Earnings Yield
-7.62%

Stock Price Statistics

Beta
1.10
52-Week Price Change
-16.81%
50-Day Moving Average
93.27
200-Day Moving Average
95.45
Relative Strength Index (RSI)
40.55
Average Volume (3m)
24.56K

Important Dates

BioNTech SE upcoming earnings date is Mar 02, 2027, Before Open (Not Confirmed).

Last Earnings Date
Nov 03, 2026
Next Earnings Date
Mar 02, 2027
Ex-Dividend Date
―

Financial Position

BioNTech SE as a current ratio of 7.54, with Debt / Equity ratio of 1.39%

Current Ratio
7.54
Quick Ratio
7.49
Debt to Market Cap
0.00
Net Debt to EBITDA
11.79
Interest Coverage Ratio
-45.74

Taxes

In the past 12 months, BioNTech SE has paid 81.93M in taxes.

Income Tax
81.93M
Effective Tax Rate
-0.08

Enterprise Valuation

BioNTech SE EV to EBITDA ratio is -22.28, with an EV/FCF ratio of -20.32.

EV to Sales
3.95
EV to EBITDA
-22.28
EV to Free Cash Flow
-20.32
EV to Operating Cash Flow
-38.79

Balance Sheet

BioNTech SE has $10.20B in cash and marketable securities with $359.80M in debt, giving a net cash position of $9.84B billion.

Cash & Marketable Securities
$10.20B
Total Debt
$359.80M
Net Cash
$9.84B
Net Cash Per Share
$39.18
Tangible Book Value Per Share
$64.80

Margins

Gross margin is 67.86%, with operating margin of -63.12%, and net profit margin of -61.53%.

Gross Margin
67.86%
Operating Margin
-63.12%
Pretax Margin
-59.89%
Net Profit Margin
-61.53%
EBITDA Margin
-17.72%
EBIT Margin
-54.50%

Analyst Forecast

The average price target for BioNTech SE is $121.21, which is 11.43% higher than the current price. The consensus rating is Strong Buy

Price Target
$121.21
Price Target Upside
40.85% Upside
Analyst Consensus
Strong Buy
Analyst Count
16
Revenue Growth Forecast
-20.72%
EPS Growth Forecast
-160.57%

Scores

Smart Score
6
AI Score
―